Molecular Profile | Unknown unknown |
Therapy | Nintedanib |
Indication/Tumor Type | colorectal cancer |
Response Type | not applicable |
Create By | cstatz |
Update By | spatt |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References | Unknown unknown | colorectal cancer | not applicable | Nintedanib | Phase I | Actionable | In a Phase I trial, Ofev (nintedanib) demonstrated safety and efficacy in patients with advanced colorectal cancer (PMID: 25012508). | 25012508 |
---|
PubMed Id | Reference Title | Details |
---|---|---|
(25012508) | Vascular effects, efficacy and safety of nintedanib in patients with advanced, refractory colorectal cancer: a prospective phase I subanalysis. | Full reference... |